The Global Artificial Pancreas Devices Market Size is estimated to grow at a CAGR of 16.33% by 2032, estimates DelveInsight

DelveInsight's Artificial Pancreas Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Artificial Pancreas Devices Companies market shares, challenges, Market Drivers, barriers, trends, and key market Companies in the market.

To read more about the latest highlights related to the Artificial Pancreas Devices Market, get a snapshot of the key highlights entailed in the Market Report @ Artificial Pancreas Devices Market Size- https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Artificial Pancreas Devices Market Report
• In September 2024, Tandem Diabetes Care, Inc., announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) technology was cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the European Union (EU).
• In June 2024, MCRA, a leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm, announced its role in assisting CamDiab's artificial pancreas software, CamAPS FX, in achieving U.S. Food and Drug Administration (FDA) clearance.
• The Global Artificial Pancreas Devices Market was valued at USD 334.76 million in 2024, growing at a CAGR of 16.33% during the forecast period from 2025 to 2032, to reach USD 1,116.86 million by 2032.
• North America is expected to hold the largest share of the artificial pancreas device market in 2024.
• The leading Artificial Pancreas Devices Companies such as Medtronic PLC, Insulet Corporation, Tandem Diabetes Care, Inc., Beta Bionics, Inc., BIGFOOT BIOMEDICAL, INC., CamDiab Ltd., Diabeloop SA, Ypsomed, INREDA® DIABETIC B.V., Nikkiso Co., Ltd., Pancreum, Inc., Johnson & Johnson Services, Inc., Dexcom, Inc., TypeZero Technologies, Animas Corporation, and others.

To know more about why North America is leading the market growth in the Artificial Pancreas Devices Market, get a snapshot @ Artificial Pancreas Devices Market Outlook- https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Pancreas Devices Market Dynamics
Additionally, according to the recent update provided by the International Diabetes Federation, in 2021, approximately 537 million adults aged 20-79 were living with diabetes globally. This number was projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, as per the recent data provided by the IDF Diabetes Atlas, in 2022, out of the 8.75 million people living with type 1 diabetes worldwide, 1.52 million were under 20 years old. However, 62% of all new type 1 diabetes cases in 2022 occurred in people aged 20 years or older. With diabetes being a chronic condition that demands continuous monitoring and precise insulin administration, artificial pancreas systems, which combine insulin pumps and continuous glucose monitoring (CGM) to provide automated insulin delivery, offer a significant improvement in the quality of life for diabetes patients.

Artificial Pancreas Devices Market Segmentation
Artificial Pancreas Device Market by Device Type (Threshold Suspended Device System and Non-Threshold Suspended Device System), End User (Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Artificial Pancreas Devices Market Dynamics @ Artificial Pancreas Devices Market Dynamics Analysis- https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Pancreas Devices Companies
Medtronic PLC, Insulet Corporation, Tandem Diabetes Care, Inc., Beta Bionics, Inc., BIGFOOT BIOMEDICAL, INC., CamDiab Ltd., Diabeloop SA, Ypsomed, INREDA® DIABETIC B.V., Nikkiso Co., Ltd., Pancreum, Inc., Johnson & Johnson Services, Inc., Dexcom, Inc., TypeZero Technologies, Animas Corporation, and others.

Artificial Pancreas Devices Market Drivers
The rising incidence of diabetes globally is a significant driver of the artificial pancreas device market, as the growing patient population increases the demand for effective diabetes management solutions. Additionally, increasing awareness of diabetes and the implementation of screening programs have led to earlier diagnosis and better disease management, further supporting the need for advanced technologies like artificial pancreas systems. Moreover, increased product development activities by key players have resulted in improved and innovative artificial pancreas devices, enhancing their efficiency and accessibility. Collectively, these factors are expected to contribute to the expansion of the artificial pancreas device market during the forecast period from 2025 to 2032.

Which MedTech key players in the Artificial Pancreas Devices Market are set to emerge as the trendsetter explore @ Artificial Pancreas Devices Companies- https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Artificial Pancreas Devices Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Artificial Pancreas Devices Companies- Medtronic PLC, Insulet Corporation, Tandem Diabetes Care, Inc., Beta Bionics, Inc., BIGFOOT BIOMEDICAL, INC., CamDiab Ltd., Diabeloop SA, Ypsomed, INREDA® DIABETIC B.V., Nikkiso Co., Ltd., Pancreum, Inc., Johnson & Johnson Services, Inc., Dexcom, Inc., TypeZero Technologies, Animas Corporation, and others.

Interested in knowing the Artificial Pancreas Devices Market by 2032? Click to get a snapshot of the Artificial Pancreas Devices Market Trends- https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Artificial Pancreas Device Market Report Introduction
2. Artificial Pancreas Device Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Artificial Pancreas Device Market Key Factors Analysis
6. Artificial Pancreas Device Market Porter's Five Forces Analysis
7. Artificial Pancreas Device Market Assessment
8. Artificial Pancreas Device Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

This release was published on openPR.